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Introduction {#sec1}
============

Huntington\'s disease (HD) is an autosomal dominant CAG-repeat neurodegenerative disease ([@bib25]). Mutation of the huntingtin (*HTT*) gene results in an expanded polyglutamine (Q^n^) repeat within the HTT (mHTT) protein. Individuals with ≥40Q develop HD, with juvenile-onset cases before age 20 years typically occurring above 60 repeats ([@bib11]). HD symptoms include uncontrollable movement, psychiatric disturbances, and cognitive impairment ([@bib47]) with progressive neurodegeneration and brain atrophy. The primary cell type that degenerates is medium spiny neurons (MSNs) of the striatum, and there remain gaps in our knowledge of early and initiating events in HD systems.

Due to the degenerative nature of HD, postmortem human tissues limit our understanding of early neuropathology of affected brain regions. Human induced pluripotent stem cells (iPSCs) have emerged as important models to study neurodegenerative disease mechanisms ([@bib40]). HD iPSCs differentiated to neural lineages have elucidated deficits in axonal guidance, lipid metabolism, and neuronal development and function ([@bib10], [@bib22], [@bib50]), and dysregulation of the transforming growth factor β ([@bib6], [@bib41]), wingless-related integration site (WNT) ([@bib27]), and p53 ([@bib21], [@bib41]) signaling pathways.

Increased cell proliferation in HD patient brains proportional to disease grade in the subependymal layer that overlies the degenerating caudate nucleus ([@bib12], [@bib13]) suggests increased neurogenesis in the adult brain, potentially as an adaptation to disease. Using HD iPSC-derived neuronal cultures and differentiated embryonic stem cells (ESCs), dysregulation of neurodevelopmental pathways implicates deficits in striatal maturation ([@bib53]). These signaling deficits occur early and are associated with phenotypes such as increased vulnerability to growth factor withdrawal in persistent neural progenitors ([@bib32], [@bib41]), suggesting that while neurogenesis is initiated, neuronal maturation may be impaired, leaving developmentally arrested cells vulnerable to cellular stressors. The mechanisms involved remain undefined, and these studies have primarily centered on highly expanded juvenile-onset repeat lines, with little known about the more prevalent adult-onset repeat-induced mechanisms.

Here, we use a multi-omics approach to investigate mHTT-associated molecular phenotypes using a modified protocol to differentiate HD patient iPSCs into highly pure populations of neurons with striatal characteristics. RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) analysis reveal significant dysregulation in cell-cycle-associated gene ontology (GO) terms. We show the persistence of a cyclin D1^+^ mitotic cellular population that emerges among neural progenitors in adult-onset lines and is maintained through terminal differentiation. Single-cell RNA-seq (scRNA-seq) confirms that cell-cycle-related signaling cues arise from the mitotic population of cells, identified as neural stem cells (NSCs), rather than the striatal neurons present in the same population. Furthermore, we show that the persistence of NSC populations is the result of aberrant WNT signaling and we can ameliorate this population through WNT inhibition. This perhaps identifies a pathway or mechanistic target for future therapeutic exploration.

Results {#sec2}
=======

Modified Protocol for Differentiation of iPSCs to Pure Neurons for Epigenomic Study {#sec2.1}
-----------------------------------------------------------------------------------

Our goal was to define epigenetic signatures of neuronal cultures enriched for MSNs. iPSCs were differentiated to electrophysiologically active neurons ([@bib2], [@bib49]) with the addition of activin A to promote the formation of lateral ganglionic eminence (LGE)-like progenitors and the subsequent systematic programming of neural progenitors. Comparing the previous protocol (referred to as LI, due to the media containing LDN193189 and IWR1) ([@bib49]) to this protocol with addition of activin A (LIA = medium containing LDN193189, IWR1, and activin A), we observe an increase in the co-staining of Protein Phosphatase 1 Regulatory Inhibitor Subunit 1B (PPP1R1B, alias DARPP-32) and B-cell lymphoma/leukemia 11B (BCL-11B or CTIP-2) when tested on 33Q control neuronal cultures without any noticeable change to overall neuronal maturation, as seen using phase-contrast microscopy. There is no change in the proliferation of these cell lines at the neural progenitor day 16 stage ([Figure S1](#mmc1){ref-type="supplementary-material"}). Four control lines (CS25iCTR18n2---18Qn2, CS25iCTR18Qn6---18n6, CS14iCTR28n6---28Qn6 \[28Q\], CS83iCTR33n1---33Qn1 \[33Q\]), two adult-onset lines (CS04iHD46n10---46Qn10 \[46Q\] and CS03iHD53n3---53Qn3 \[53Q\]), and three juvenile-range repeat lines (CS02iHD66n4---66n4 \[66Q\], CS81iHD71n3---71n3 \[71Q\], CS09iHD109n1---109n1 \[109Q\]) were differentiated over 37 days to mature neuronal cultures in duplicate (18Qn2, 46Q) or triplicate (18Qn6, 28Q, 33Q, 53Q, 66Q, 71Q, 109Q) ([Figure 1](#fig1){ref-type="fig"}). Quality control measures were performed ([Table S1](#mmc1){ref-type="supplementary-material"}). To control for sex effects, these lines include male (18Q, 46Q, 53Q) and female subjects (28Q, 33Q, 66Q, 71Q, 109Q). Mature neurons were defined by microtubule-associated protein 2 (MAP-2) expression and striatal neurons by DARPP-32 and BCL-11B co-staining ([Figure S2](#mmc1){ref-type="supplementary-material"}); quantification can be found in [Table S1](#mmc1){ref-type="supplementary-material"}. The 46Q iPSC line was the only sample not to reach 10% DARPP-32 expression in the total population following differentiation ([Table S1](#mmc1){ref-type="supplementary-material"}). As this differentiation protocol provides a high percentage of mature neurons (79%--98% MAP-2^+^ for all cell lines), the following data represent a multi-omics analysis of mature neuronal cultures enriched for striatal characteristics derived from iPSCs within the context of HD.Figure 1Differentiation Protocol for iPSC-Derived Striatal Neuronal Cultures(A) Schematic of the differentiation protocol used for iPSC-derived striatal neurons enriched for medium spiny neurons (MSNs) adapted from [@bib49].(B) Representative immunofluorescence images of cells at day 37 in control (top) and HD (bottom) cells showing that the cells are positive and co-localize for DARPP-32 and BCL-11B (left); cells are also positive for FOX-P1 and MAP-2 (middle) and are GABAergic, as they express the glutamate decarboxylase-2 enzyme (right). Scale bar, 20 μm.

Transcriptomics Reveal an Upregulation of Cell-Cycle-Related Genes in HD {#sec2.2}
------------------------------------------------------------------------

Bulk, total RNA-seq was used to identify differentially expressed genes (DEGs) between control and HD mature neuronal cultures enriched for MSNs. Gene expression values and DEGs were used for principal component analysis (PCA), GO enrichment analysis (GOrilla) and Ingenuity Pathway Analysis. Curiously, PCA of control (red) and juvenile-repeat range (green) lines shows no clear separation ([Figure S3](#mmc1){ref-type="supplementary-material"}). Only 105 DEGs were identified ([Table S2](#mmc2){ref-type="supplementary-material"}, columns A--H) when comparing highly expanded repeat lines with controls, and there was no enrichment for specific GO terms, although RE1 Silencing Transcription Factor (REST) was downregulated as described in neural cultures ([@bib7], [@bib22]). Finding limited DEGs was surprising given the documented transcriptional dysregulation in HD and in models expressing juvenile-range repeat lengths ([@bib52]). Control (red) and adult-onset (blue) lines, however, show separation along principal component 1 (PC1) ([Figure 2](#fig2){ref-type="fig"}A). Given the statistical difference between the control and adult-onset lines and the biological relevance of exploring CAG-repeat lengths more prevalent in the HD population, we continued our analysis to define transcriptional differences between control and adult-onset lines. We identified 823 DEGs in adult-onset neuronal cultures enriched for MSNs compared with control lines (10% false discovery rate \[FDR\] cutoff), with 754 genes upregulated and 69 genes downregulated ([Table S2](#mmc2){ref-type="supplementary-material"}, columns I--P). The top genes by adjusted p value are labeled in a volcano plot ([Figure 2](#fig2){ref-type="fig"}B). Interestingly, the second most statistically significantly upregulated gene was the pluripotency marker POU domain, class 5, transcription factor 1 (*POU5F1*, alias *Oct4*) whereas other markers of pluripotency were not dysregulated (NANOG homeobox gene \[*NANOG*\], Podocalyxin like \[*PODXL*, alias *TRA-1-81*\], Kruppel-like factor 4 \[*KLF4*\], MYC proto-oncogene \[*MYC*\]). GO enrichment revealed dysregulation of cell-cycle-associated biological processes ([Figure 2](#fig2){ref-type="fig"}C), DNA-binding-associated molecular functions ([Figure 2](#fig2){ref-type="fig"}D), and chromosomal gene-associated cellular components ([Figure 2](#fig2){ref-type="fig"}E). The top cellular function, predicted to be activated, is cell-cycle progression, with a p value of 7.57 × 10^−39^.Figure 2Cell-Cycle-Related Genes Are Upregulated in HD Adult-Onset Cell Lines by RNA-Seq(A) PCA of global gene expression in HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) iPSC-derived striatal neurons. PC1, which captures the most gene expression variance between samples, shows separation of HD and control samples.(B) Volcano plot showing statistically significant DEGs (light blue) between HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) samples. The most significant genes, by FDR, are labeled. Significant gene expression differences are skewed, showing many more upregulated DEGs in the HD samples ([Table S2](#mmc2){ref-type="supplementary-material"}, columns A--H).(C--E) Top GO enrichment analysis terms for biological process (C), molecular function (D), and cellular components (E) showing enrichment for cell cycle, DNA binding, extracellular matrix, and chromosomal genes.

Upregulation of Cell-Cycle-Related Genes and Transcription Factors in HD Identified Using Epigenomic Analysis {#sec2.3}
-------------------------------------------------------------------------------------------------------------

We performed ChIP-seq on trimethylated, histone 3 lysine 4 (H3K4me3) residues to identify active promoters in control (18Qn2, 18Qn6, 28Q, 33Q) and HD (46Q, 53Q) neuronal cultures, whereby 99,765 K4me3 sites were found across the lines. Differential analysis of K4me3 occupancy between control and HD lines identified 2,153 sites (5% FDR cutoff); 1,133 of the sites had higher K4me3 levels in HD and 764 sites had higher levels in controls. PCA of differential peaks ([Figure 3](#fig3){ref-type="fig"}A) shows clear separation between control and HD K4me3-enriched signals. Differential peaks were annotated to 1,340 genes within a window of 10 kb from transcription start sites (TSS), with a majority of the genes (1,143 genes) having an upregulated K4me3 signal in HD. GO enrichment analysis of the genes annotated to the differential sites shows enrichment of cell-cycle-related terms ([Figure 3](#fig3){ref-type="fig"}B).Figure 3Epigenomics Upregulation of Cell-Cycle-Related Genes in HD(A) PCA of K4me3 sites identified by ChIP-seq in HD (46Q and 53Q) and control (18Q, 28Q, and 33Q) iPSC-derived striatal neurons.(B) Top GO enrichment analysis terms for genes near K4me3 differential sites show enrichment for cell cycle.(C) Venn diagram of genes upregulated in HD in RNA-seq and ChIP-seq. Upregulated K4me3 sites were found near the TSS of almost half of the transcriptionally upregulated genes in HD.(D) Top GO enrichment analysis terms for the RNA and ChIP-seq overlapping genes show enrichment for cell-cycle processes.(E) Transcription factor (TF) analysis of the regulatory sites near genes upregulated in both RNA and ChIP-seq. Cell-cycle-related TF-binding sites are enriched in HD.

We overlapped the ChIP-seq and RNA-seq differential signals and found that almost half of the transcriptionally upregulated genes in HD (327 DEGs) had K4me3-upregulated sites in the area next to their TSS ([Figure 3](#fig3){ref-type="fig"}C). The subset of genes upregulated both transcriptionally and epigenetically show higher enrichment for cell-cycle GO terms (compare [Figures 3](#fig3){ref-type="fig"}D and 3B). We used Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq) data to localize the transcription factor (TF)-binding sites within the K4me3 differential sites adjusted to the upregulated DEGs. TF analysis of these sites suggests enrichment for binding of several TFs related to cell-cycle regulation in HD lines ([Figure 3](#fig3){ref-type="fig"}E).

Adult-Onset HD Cell Lines Have a Persistent Mitotically Active Population in Neuronal Cultures {#sec2.4}
----------------------------------------------------------------------------------------------

Additional adult-onset HD lines were added to the study to determine whether the altered mitotic signature was maintained across different subjects. Within each of the terminally differentiated adult-onset lines, we observe novel populations comprising cells with enlarged cell bodies that lack projections, which are quite distinct from neurons and are absent in control cell lines ([Figure 4](#fig4){ref-type="fig"}A). These morphologically distinct cell clusters are readily apparent at the end of culture, as identified by phase-contrast microscopy. These cells are visible at low frequency at day 18 and are observed at higher frequency by day 23 among differentiating neurons. These cell clusters are present in each of four adult-onset HD cell lines examined (CS13iHD43n13 \[43Q\], 46Q, CS87iHD50n7---50Qn7 \[50Q\], 53Q) by immunofluorescence and phase-contrast microscopy ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). These aberrant cells are positive for the cell-cycle G~1~/S phase transition marker cyclin D1, the pluripotency marker Oct4, and the neuroectoderm marker nestin, and are negative for the neuronal marker MAP-2 ([Figure 4](#fig4){ref-type="fig"}B), an unexpected finding given that the differentiation protocol produces terminally differentiated, post-mitotic, mature neurons. This population is not the result of the LIA-adapted neural progenitor specification adopted in our protocol, as it is also observed using the previously published LI protocol ([@bib49]) ([Figures S1](#mmc1){ref-type="supplementary-material"}D and [S4](#mmc1){ref-type="supplementary-material"}A), which is important given the role that activin A can play in pluripotency ([@bib5]).Figure 4High Percentage of Adult-Onset HD Neuronal Populations Express Cyclin D1 Compared with Controls(A) Phase-contrast images show control (top) and HD (bottom) neurons, with the mitotic population persisting in the HD line occupying the majority of the field. Scale bar, 100 μm.(B) Assessment of the cyclin D1^+^ population by immunofluorescence shows co-staining of cyclin D1 with nestin (top) and Oct4 (middle), and no co-staining with MAP-2 (bottom). Scale bar, 20 μm. Images are representative of the four adult-onset lines tested (43Q, 46Q, 50Q, 53Q), quantification for which can be found in [Figure S4](#mmc1){ref-type="supplementary-material"}A.(C) Analysis of cyclin D1 expression by flow cytometry shows a significant increase in percentage of cells expressing cyclin D1 compared with controls. Data were acquired across three experiments using three cell lines per condition for two experiments (18Q, 20Q, 33Q, 46Q, 50Q, 53Q) and one experiment with two lines per condition (18Q, 20Q, 50Q, 53Q). Data represent mean ± SEM. Unpaired one-tailed t test, t = 9.539, df = 4, p = 0.0003, \*\*\*p \< 0.001.(D) Analysis of co-markers of HD cyclin D1^+^ cells by flow cytometry shows that the majority of cyclin D1^+^ cells are Oct4^+^ and nestin^+^. Data from 50Q and 53Q (nestin), n = 1 HD cell line; data from 46Q, 50Q, 53Q (Oct4), n = 2 HD cell lines. Data represent mean ± SEM.

Flow cytometry was used to quantify the percentage of the population composed of cyclin D1^+^ cells, which revealed a significant increase (p = 0.0003) of cyclin D1^+^ cells (48.46% ± 4.54%) in terminally differentiated HD lines compared with controls (3.654% ± 1.206%) when grouped together ([Figure 4](#fig4){ref-type="fig"}C). Separately, HD lines (50Q, 53Q) have significantly more cyclin D1^+^ cells than controls (18Qn6 \[18Q\], CS71iCTR20n6---20Qn6 \[20Q\]) ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Almost all of the cyclin D1^+^ cells were also nestin positive (98.5% ± 0.55%) and a high proportion of them were Oct4 positive (73.9% ± 14.1%) ([Figure 4](#fig4){ref-type="fig"}D), implying that Oct4 and nestin are expressed in the same cells in a large proportion of the cyclin D1^+^ population. Of the total day-37 population, Oct4 was expressed at very low levels in control cells (1.03% ± 0.20%) and higher in adult-onset HD cells (22.7% ± 4.34%) ([Figure S5](#mmc1){ref-type="supplementary-material"}). Importantly, there was a very low percentage (\<0.054%: 20Q, 46Q, 50Q) of Oct4-positive cells in cultures at early stages (day 8) ([Figure S5](#mmc1){ref-type="supplementary-material"}). Cyclin D1^+^ cells are proliferative throughout terminal differentiation, and increasingly make up more of the total population as the number of days *in vitro* progresses; however, this does not seem to have a detrimental effect on the remaining post-mitotic neurons.

Single-Cell RNA-Seq Identifies the Cyclin D1^+^ Population Specific to Adult-Onset Lines as NSCs {#sec2.5}
------------------------------------------------------------------------------------------------

To define the composition of the persistent cyclin D1^+^ cell population present in HD cultures, we performed scRNA-seq on neuronal populations differentiated from one representative control (18Qn6---18Q) and HD iPSC line (53Q). Single-cell viability for each sample was determined (86.9% for 18Q, 80.9% for 53Q). The estimated number of cells sampled was 5,070 (18Q) and 3,829 (53Q) with an average number of reads per cell of 31,675 (18Q) and 41,939 (53Q). After quality control of data filtering, the data were aggregated using Cell Ranger and gene-by-cell expression matrices generated and used as input for Seurat and Scanpy. The top variable genes by PCA were used for exploratory analysis and visualization using t-distributed stochastic neighbor embedding (t-SNE) ([Figure 5](#fig5){ref-type="fig"}A). An unsupervised clustering approach identified seven distinct cell clusters, which were annotated using known cell-type markers ([Figure 5](#fig5){ref-type="fig"}B and data not shown). The NSC cluster ([Figure 5](#fig5){ref-type="fig"}A) is specific to the HD cell line, with the remaining clusters contributed to by both cell lines. None of the clusters express the astrocyte marker S100 calcium-binding protein β (*S100β*) or glial fibrillary acidic protein (*GFAP*), and most clusters express the neuronal marker *MAP2*, with the neural progenitor marker *NES* only expressed in the green and brown clusters. Only the NSC cluster in the HD line had high levels of *CCND1*. *CCND1* identifies the aberrant HD population, and we find that other genes are also upregulated in this cluster that are either lowly or not expressed in the other six clusters ([Table S2](#mmc2){ref-type="supplementary-material"}, columns Q--V), including the progenitor marker *NES* and SRY-box transcription factor 2 (*SOX2*), which identifies these cells as an NSC-type population.Figure 5scRNA-Seq Reveals a Unique Population of Cells Only in the Adult HD Sample(A) t-SNE plot of the aggregated scRNA-seq data from both the control (18Q) and HD (53Q) samples showing seven cell clusters. Clusters were annotated using known cell-type marker genes and are: mature neuron (blue; TPD52 like 1 \[*TPD52L1*\], myocyte enhancer factor 2C \[*MEF2C*\], paired box 6 \[*PAX6*\], and SIX homeobox 3 \[*SIX3*\]); D1 and D2^+^ spiny neurons (orange; Meis homeobox 2 \[*MEIS2*\], distal-less homeobox 5 \[*DLX5*\], hippocalcin \[*HPCA*\]); NSC cluster (green; nestin \[*NES*\], cyclin D1 \[*CCND1*\]); D1^+^ spiny and cholinergic striatal neurons (red; *DLX5*, ISL LIM homeobox 1 \[*ISL1*\], Rac family small GTPase 3 \[*RAC3*\], arginase 2 \[*ARG2*\]); D1^+^ spiny neurons (purple; *MEIS2*, protein phosphatase 1 regulatory inhibitor subunit 1A \[*PPP1R1A*\], CaM kinase-like vesicle associated \[*CAMKV*\], *RAC3*, glutamate ionotropic receptor NMDA type subunit 2B \[*GRIN2B*\]); neural progenitor cells (NPCs) (brown; *CCND1*, homer scaffold protein 3 \[*HOMER3*\], EBF transcription factor 1 \[*EBF1*\]); and immature neurons (pink; VGF nerve growth factor inducible \[*VGF*\], H1 histone family member 0 \[*H1F0*\]).(B) Stacked violin plot showing expression of glial, neural, and neuronal cell-type markers. *CCND1* expression is mainly visible in the NSC cluster, which only exists in the HD (53Q) sample.

While the signal from the NSCs likely obscured gene expression differences from the neuronal population in our bulk RNA-seq dataset, scRNA-seq allowed for the identification of gene expression differences in *MAP2*^+^, *NES*/*SOX2*^−^ neurons between HD and control lines ([Table S2](#mmc2){ref-type="supplementary-material"}, columns W--AB). In this population, genes known to be dysregulated in HD were observed, some of which are: activity-regulated cytoskeleton associated protein (*ARC*), Fos proto-oncogene, AP-1 transcription factor subunit (*FOS*), JunB proto-oncogene, AP-1 transcription factor subunit (*JUNB*), neuronal PAS domain protein 4 (*NPAS4*), and neurogranin (*NRGN*), suggesting the possibility that these populations contribute to previously defined HD molecular signatures.

Inhibition of the WNT Signaling Pathway Abrogates NSC Populations in HD Neuronal Cultures {#sec2.6}
-----------------------------------------------------------------------------------------

Two of the top three transcriptional regulators with the largest changes in RNA-seq expression are transcriptionally regulated by WNT signaling: *Oct4* (*POU5f1*, 6.479-fold increase) and *CCND1* (5.186-fold increase). Analysis of TF-binding sites demonstrates that two of the top four regulatory motifs near genes upregulated in both RNA-seq and ChIP-seq are *MYC* and *E2F*, which are both involved with WNT signaling ([@bib24], [@bib46], [@bib54]) ([Figure 3](#fig3){ref-type="fig"}E). Examination of the WNT/β-catenin signaling pathway reveals significant dysregulation of several key members, including components of the β-catenin destruction complex, APC regulator of WNT signaling pathway (*APC*), and glycogen synthase kinase 3β (*GSK3β*) downregulated in HD lines ([Figure 6](#fig6){ref-type="fig"}A). Additionally, scRNA-seq demonstrates that the dysregulation we observe in the WNT/β-catenin signaling pathway from the bulk analysis resides in the NSC population, which has increased expression of Wingless-Type MMTV Integration Site Family, Member 7A (*WNT7A*), increased expression of Transcription Factor 3 (TCF3), increased expression of frizzled transcripts (frizzled class receptor 2 \[*FZD2*\] and frizzled class receptor 7 \[*FZD7*\]), decreased expression of β-catenin destruction complex transcripts (*APC* and *GSK3β*), and increased expression of WNT transcriptional targets (*CCND1*) ([Figure 6](#fig6){ref-type="fig"}B). We were unable to detect *POU5f1* expression in many of the HD cells (about 90 positive cells in HD lines and three positive cells in controls), presumably due to lower sequencing depth using the scRNA-seq platform.Figure 6WNT/β-Catenin Signaling Is Significantly Dysregulated and WNT Inhibition Rescues Aberrant Cyclin D1 Overexpression while Abrogating the Mitotic Population of Cells in Adult-Onset Neurons(A) Dysregulation of the WNT/β-catenin signaling pathway from bulk RNA-seq was analyzed using Ingenuity Pathway Analysis. While Frizzled receptors are upregulated, members of the β-catenin destruction complex, specifically *APC* and *GSK3β*, are downregulated, allowing for upregulation of WNT/β-catenin transcriptional targets, such as *CCND1* and Oct4 (*POU5F1*). Orange molecules are upregulated, blue are downregulated, and black are targeted for destruction. A full legend can be found in [Figure S5](#mmc1){ref-type="supplementary-material"}. 46Q and 53Q lines were compared with controls with 18Q (2 clones), 28Q, and 33Q in triplicate using a 0.1 FDR.(B) Dot plots show expression of WNT/β-catenin pathway genes and *CCND1*. The NSC cluster shows higher expression of all WNT-related genes except for genes of the destruction complex, *APC* and *GSK3β*, and *WNT7A*, which shows higher expression in the NSC cluster over all other clusters besides the cortical cluster.(C) The WNT inhibitor ICG or DMSO was added to the NPC population at day 16 of differentiation. Cells were harvested at day 37 and western blots were performed for cyclin D1, MAP-2, synaptophysin, and PSD95 using LI-COR.(D) Quantitation demonstrates that treatment with ICG completely rescues aberrant overexpression of cyclin D1 in adult-onset striatal neurons (50Q and 53Q). For analysis, lines were grouped by genotype. White bars represent DMSO-treated cells and black bars represent ICG-treated cells. Analysis was done using a two-way ANOVA with Bonferroni correction. Multiplicity-adjusted p values were calculated for each comparison at a 95% confidence interval. Data represent mean ± SEM. ^∗∗∗∗^p \< 0.0001. Data are from two independent experiments using four cell lines grouped by control (18Q, 20Q) and HD (50Q, 53Q). Further statistical details can be found in [Tables S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}.(E) Representative phase images show the mitotic population of cells at day 37 in adult-onset line (53Q) treated with DMSO (top-right panel), which is completely abrogated by ICG addition (bottom-right panel). The 53Q line is a representative adult-onset line. Scale bar, 100 μm.

Because of the regulatory role of WNT/β-catenin over the expression of mitotic and pluripotency genes, we hypothesized that downstream correction of the WNT/β-catenin signaling pathway might reduce the mitotic cues necessary for the persistence of the NSC population in HD lines. Therefore, we titrated several WNT inhibitors that act downstream of the β-catenin destruction complex and found that the addition of ICG-001 (hereafter ICG) eliminates the mitotic cell population within HD neuronal cultures. ICG is a selective, potent inhibitor of β-catenin-mediated transcription by preventing the interaction between CREB-binding protein and β-catenin ([@bib18]). ICG addition at day 16 in the differentiation protocol significantly reduced cyclin D1 protein expression in HD lines (50Q, 53Q) by a factor of 10 ([Figures 6](#fig6){ref-type="fig"}C and 6D). A highly expanded repeat line (109Q) was assessed to determine the potential effect of ICG based on polyQ length; however, no additional effect was observed ([Figure S6](#mmc1){ref-type="supplementary-material"}). Representative phase-contrast images of a representative adult-onset line (53Q; [Figure 6](#fig6){ref-type="fig"}E) demonstrate that ICG treatment abrogates the morphologically distinct NSC populations within adult-onset HD neuronal cultures. Additionally, ICG does not alter MAP-2 expression ([Figure S6](#mmc1){ref-type="supplementary-material"}A), suggesting that the presence of neurons is not altered by treatment. While expression of synaptophysin and Disks Large MAGUK Scaffold Protein 4 (alias PSD95) remain unchanged in HD lines ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C), expression of both is reduced in control lines by ICG treatment ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Notably, for these differentiations the 50Q line overwhelmingly had the highest percentage of mitotic cells and therefore, correspondingly, DMSO-treated 50Q cells have the lowest levels of MAP-2, PSD95, and synaptophysin overall.

Discussion {#sec3}
==========

Multi-omics-level analyses were performed on HD neuronal cultures enriched for MSNs using a protocol that induces increased expression of LGE markers including distal-less homeobox 1 and 2 (*DLX1/2*) and GS homeobox 2 (*GSX2*) mRNA. This response is likely via upregulation of BCL-11B, which is important for MSN development ([@bib3]). Introduction of activin A increased co-localization of BCL-11B and DARPP-32^+^ neurons, which is more indicative of MSNs than DARPP-32 positivity alone ([@bib9]). Total RNA-seq and scRNA-seq showed that the primary transcriptional differences were reflected in a persistent population of NSCs within terminally differentiated, post-mitotic neuronal cultures from patients with adult-onset repeats. These findings are consistent with mitotic aberrations found in HD iPSCs differentiated toward a striatal lineage ([@bib32]). Here, we uncover a key mechanism underlying this mitotic persistence.

mHTT has an impact on neurogenesis in HD knockin ([@bib36]), transgenic R6/1 ([@bib26]), and R6/2 ([@bib39]) mouse models, and patient postmortem tissue ([@bib12], [@bib13]). Neurodevelopmental changes associated with mHTT expression are observed in other stem cell-derived models: *HTT*-null NSCs derived from mouse ESCs ([@bib30]), HD patient-derived iPSC striatal cells ([@bib10]), and an isogenic allelic series of human ESCs differentiated toward a cortical neuron fate form disorganized neural rosettes ([@bib44]), suggesting HD-related aberrations during development of the neural tube. While technical limitations of scRNA-seq limit analysis of *Oct4* transcript abundance specifically within the NSC population, our observation of *Oct4* persistence by bulk RNA-seq is corroborated by persistent Oct4 expression found in neuronal differentiations ([@bib10]). Expression of mHTT impairs Oct4 protein downregulation even in highly expanded repeat lines (60Q, 109Q, 180Q) during differentiation when control cultures transition from pluripotency to neuroectoderm formation. Aberrant maintenance of Oct4 expression in ESC-derived neuronal cultures has also been noted with expanded CAG repeats in other contexts, for example within the hypoxanthine phosphoribosyltransferase (*Hprt*) gene ([@bib29]). Temporal dysregulation of other developmental markers has also been observed; juvenile HD iPSCs differentiated toward a striatal fate maintain nestin^+^ NPCs susceptible to death by brain-derived neurotrophic factor withdrawal, suggesting that mitotically persistent populations of cells are vulnerable to factors mimicking the HD environment ([@bib32]). These nestin^+^ NPCs were reduced by targeting the canonical Notch signaling pathway and lowering HTT by antisense oligonucleotide treatment ([@bib31]). Additionally, transcriptomic analysis of HD iPSC isogenic lines showed that differences related to neuronal development and dorsal striatum formation occur at the NSC stage ([@bib41]), further implicating the NSC stage in manifestation of developmental aberrations due to mHTT expression. In HD patient iPSC-derived neural cultures, one-third of all gene expression changes were related to pathways involved in neuronal development and maturation ([@bib22]).

Several studies have implicated mitotic persistence in altered neurogenesis in HD ([@bib1], [@bib37]). ESC-isogenic HD lines differentiated into forebrain neuronal cultures showed altered transcriptional signatures for cell-cycle progression. Other studies implicated cell-cycle re-entry as a mechanism of mitotic dysregulation in HD ([@bib15], [@bib28], [@bib38]) and other neurodegenerative diseases ([@bib23], [@bib45]). In contrast, our data indicate a failure to exit the cell cycle as the primary mechanism of persistent mitosis. It is possible that rare cells persist randomly and give rise to a proliferating population during differentiation as opposed to a specific mHTT-mediated effect; however, this is unlikely given that this persistent mitotic population is only observed in the adult-onset lines, not control lines, and is present in all adult-onset lines tested (n = 4). Furthermore, scRNA-seq data showed no clusters having significant differentially expressed levels of *CCND1* between HD and control cells that also showed high levels of mature neuronal marker expression, which would be expected if mature neurons were re-entering the cell cycle.

The work presented offers a mechanism for mitotic persistence, aberrant WNT signaling leading to propagation of mitotic cell populations. This prolonged mitotic state may underlie the transient excess neurogenesis observed in animal models of HD and patient adult striatum ([@bib12], [@bib19], [@bib48]). Altered WNT signaling is implicated in HD pathogenesis. β-Catenin pathway modulation rescued the toxic effects of mHTT expression and increased the life span in HD *Drosophila*, attenuated neurodegeneration of primary striatal neurons ([@bib20]), and WNT dysregulation may promote aberrant angiogenesis-related signaling observed in HD iPSC-brain microvascular endothelial cells ([@bib27]), suggesting that this pathway may be critical in understanding primary mechanisms affected as a consequence of chronic mHTT expression.

While HTT interacts with the β-catenin destruction complex *in vitro* and *in vivo*, the expanded polyQ region in mHTT prevents binding, leading to toxic β-catenin stabilization and eventual neurodegeneration ([@bib20]). One possibility for the presence of the NSC population only in adult-onset and not in juvenile-range repeat HD neuronal cultures is a threshold activation of the WNT pathway controlled by polyQ length. In neurons, highly expanded polyQ lengths may cause structural changes different from those observed in adult-onset cases that further dysregulate protein-protein interactions and downstream signaling ([@bib8]) such that the highly expanded polyQ region no longer prevents β-catenin from binding the destruction complex and allows for β-catenin degradation, thus preventing transcription of WNT targets such as *CCND1* and *Oct4*. This could allow juvenile lines to follow the same developmental paradigm as control lines without the presence of aberrant NSCs in neuronal populations.

Many neuronal induction protocols exploit inhibition of the WNT pathway due to its role in determining neural crest cell fate ([@bib33]); two striatal differentiation protocols add the WNT inhibitor DKK1 after initial neural induction ([@bib4], [@bib14]). Consistent with the hypothesis that WNT may be differentially activated in the adult-onset versus juvenile-repeat striatal-enriched neuronal cultures, RNA-seq showed that β-catenin destruction complex members were downregulated in adult-onset lines compared with similar levels of both *APC* and *GSK3β* in control and juvenile lines (data not shown). With the addition of CHIR99021, the WNT agonist, in our protocol, the adult-onset lines may no longer be able to compensate for the overactivation of WNT, thereby uncovering a previously undefined mechanism.

We expected to uncover myriad cell-intrinsic differences between control and juvenile HD neuronal cultures and were surprised to find few transcriptional differences. This may be informative for the neurodegenerative disease field in the context of pure populations of iPSC-derived cell types to investigate cell-intrinsic effects. Furthermore, these findings perhaps highlight the phenotypic differences observed between adult- and juvenile-repeat HD, which present quite differently, with manifestation of dyskinesia and global neurodegeneration observed in juvenile cases not present with adult onset ([@bib43]). We do not know whether the lack of transcriptional differences between control and juvenile groups is a consequence of (1) juvenile-repeat cell cultures bypassing some point in the differentiation process, (2) cells within the juvenile-repeat lines that remain as NSCs being highly susceptible to cell death, (3) the length of the polyQ repeat expansion acting as flexible domain that modulates the spatial proximity of N17 and polyproline-flanking domains, thereby affecting downstream signaling ([@bib8]), or (4) the need for signals from other cell types for full manifestation of disease. However, regarding point (4), scRNA-seq data from *MAP2*^+^, *NES*/*SOX2*^−^ neurons identifies genes known to be dysregulated in HD neurons, suggesting that there are HD signatures in adult-onset iPSC-derived neurons that overlap with previously published data ([@bib22]). The protocol used here reflects very early cell-intrinsic effects. Thus far, we have observed the mitotic population of cells in all adult-onset lines differentiated with this protocol, but only rarely in juvenile-repeat lines and never in control lines.

Overall, our data show that there is a persistent, mitotically active cell population unique to adult-onset repeat HD cell lines that we can prevent *in vitro* by targeting the WNT pathway with the application of the WNT inhibitor ICG. While ICG is used as a tool to demonstrate the mechanism behind the persistence of NSCs in the context of HD, we speculate that specific components of the WNT signaling pathway inhibited by ICG could be therapeutic targets for HD with the potential to compensate for neurodevelopmental defects.

Experimental Procedures {#sec4}
=======================

Products were purchased from Thermo Fisher Scientific (Waltham, MA, USA), unless stated. See [Supplemental Information](#app2) for additional experimental procedures and buffer formulations.

iPSC Differentiation {#sec4.1}
--------------------

iPSC lines were generated as described by [@bib22]. iPSCs were cultured on hESC-qualified Matrigel (Corning) in mTESR1 (STEMCELL Technologies) and passaged with Versene (Gibco). At 60%--70% confluency, medium was changed to start neural differentiation as described by [@bib49] However, at day 8 cells were replated in activin A-containing medium (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Immunofluorescence {#sec4.2}
------------------

Cells grown on glass coverslips were fixed with 4% paraformaldehyde (PFA; Electron Microscopy Sciences) in PBS for 10 min. Antibody incubations and imaging are described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

RNA-Seq {#sec4.3}
-------

Total RNA was isolated using the Qiagen RNeasy Kit and QIAshredders for cell lysis. One microgram of RNA with RNA integrity number values \>9 were used for library preparation using the strand-specific Illumina TruSeq Total RNA protocol. Libraries were sequenced on the HiSeq 2500 platform using 100 cycles to obtain paired-end 100 reads at \>50 million reads per sample.

scRNA-Seq {#sec4.4}
---------

Samples for scRNA-seq were harvested using Dispase (Gibco) for 30 min at 37°C, pipetted off the plate with advanced DMEM/F12 (1:1) with 2% B27, and collected by centrifugation. Cells in 0.1% BSA PBS were filtered through a 70-μm cell strainer and counted. Cells were resuspended at 700 cells/μL in 0.04% BSA in PBS at \>80% viability.

ChIP-Seq {#sec4.5}
--------

Frozen cell pellets (minimum of two replicates per line) were resuspended in lysis buffer and incubated on ice for 20 min. Chromatin was digested and samples processed as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Libraries were prepared using NEBNExt Ultra II DNA Library Prep Kit for Illumina (NEB) and sequenced on an Illumina HiSeq 2000 for single-end 50-bp reads.

ATAC-Seq {#sec4.6}
--------

Cryostored cell samples were processed in duplicates as previously described ([@bib35]). The ATAC-seq libraries were sequenced on an Illumina HiSeq 2000 for single-end 50-bp reads.

Data Processing {#sec4.7}
---------------

For RNA-seq, fastq files were trimmed using a base quality score threshold of \>20 and aligned to the hg19 genome with TopHat 2. Reads passing quality control were used for quantification using HTSeq and analyzed with the R package DESeq2 to identify DEGs. Genes passing an FDR of 10% were used for GO enrichment analysis using GOrilla ([@bib16], [@bib17]) (<http://cbl-gorilla.cs.technion.ac.il/>).

For scRNA-seq, fastq files were quality controlled and aligned to the reference transcriptome to obtain a gene count matrix. Before downstream tertiary analysis, quality control of cells was performed by filtering out low-quality cells and low-abundance genes. After quality control and expression matrix formation, normalization was performed using UMI (unique molecular identifiers), and log transformation was used to control variance. Dimension reduction was used to visualize and explore major features of the data using PCA and t-SNE, and differential expression statistical analyses were performed using Seurat and Scanpy. Cell types were assigned based on known cell-type markers.

For ChIP-seq, fastq files were aligned to the hg38 genome assembly using Bowtie2. The ENCODE blacklist regions and PCR duplicates were removed (using SAMtools and Picard). Peak calling was done using MACS2 (\--broad flag, q-value \< 0.1). Differential analysis of the peaks was performed with Diffbind ([@bib42]) (<http://bioconductor.org/packages/DiffBind/>), using EdgeR with FDR \<0.05. Differential peaks were annotated to genes within a window of 10 kb from the TSS. GO enrichment analysis was done using Panther ([@bib34], [@bib51]) (<http://pantherdb.org/webservices/go/overrep.jsp>).

For ATAC-seq, fastq files were aligned to hg38 genome assembly using Bowtie2. ENCODE blacklist regions and PCR duplicates were removed (using SAMtools and Picard). Peak calling was done using MACS2 (\--nomodel \--shift −100 \--extsize 200 settings and q-value \< 0.05). The consensus peak file for all samples was generated using Diffbind.

Motif Analysis {#sec4.8}
--------------

HOMER (v.4.9.1) was used to identify TF motifs that are enriched in the differential ChIP-seq peaks. ATAC-seq data were used to identify TF-binding locations; thus, for motif analysis we considered consensus ATAC-seq peaks that overlap with the aforementioned differential ChIP-seq peaks. To identify enriched motifs, we used the findMotifs function in HOMER with default parameters; we looked for motif enrichment in the consensus ATAC-seq peaks within ChIP-seq differential peaks compared with a background of all consensus ATAC-seq peaks that are within 10 kb of the TSS of any gene.

Flow Cytometry {#sec4.9}
--------------

Neuronal cultures were harvested at day 37 and fixed in suspension with 4% PFA. Aliquots of cells were made for FMO (Fluorescence Minus One) and unstained controls pooled from all samples incubated for 2 h at room temperature with primary antibody, washed three times, and incubated with secondary antibody for 30 min. Cells were washed and resuspended in FACS (fluorescence-activated cell sorting) buffer, pipetted through a cell strainer (Falcon), and run on a BD LSRII flow-cytometry machine. Gating was performed using BD FACSDiva software. Further analysis was performed using De Novo FCS Express 6.

Western Blotting {#sec4.10}
----------------

Cells for western blots were scraped and harvested in cold PBS-Mg^2+^/-Ca^2+^ and flash frozen until processing. Analysis was performed using the LI-COR Odyssey CLx imaging system (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Statistical Analysis {#sec4.11}
--------------------

Error bars represent the mean ± SEM where stated. One-tailed t tests were used for comparison of two groups of data. For dataset comparisons of three or more, one-way ANOVA was used; for comparing datasets with two variables among multiple samples, two-way ANOVA was used as stated. Statistical analyses were performed using GraphPad Prism v.8 using p \< 0.05 as significant. Further information from statistical tests not in figure legends can be found in [Tables S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}. For specific assay statistical information, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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